Real-World Impact & Research

Case Studies & Publications

NHS and industry programmes on Patient Watch, plus the Royal Surrey paper-diary study and the Foot Watch photography pilot.

Get a quote View validated questionnaires

Jump to case study:

Anika Otivio IBSA Fortius Tendon Clinic Foot Watch Arthrosamid Sheffield Spine nerve root diary Royal Surrey injection follow-up

Industry Real-World Evidence Regenerative Therapies & Viscosupplementation

Anika

Clinical Setting: Anika Therapeutics (Cingal)

2026 · 12-month follow-up

Programme Overview

A Cingal outcomes pilot for Anika Therapeutics in the UK and Germany. The signed scope is up to 100 patients and 12 months of follow-up. Patients complete KOOS, with adverse events from 2 weeks, and reminders in English and German.

•KOOS at baseline, 2 weeks, 3, 6, 9, and 12 months. WOMAC was removed from the agreed scope in September 2026
•Adverse events at 2 weeks, 3, 6, 9, and 12 months
•Patient software, questionnaires, SMS, and email in English and German
•Clinicians see their own caseload. Anika sees aggregated UK and Germany views. The patient cap is 100

100patient limit across the UK and Germany

Explore real-world evidence solutions Get a quote

Post-Market Surveillance & PMCF Circulatory Medical Devices & Neurological Care

Otivio

Clinical Setting: Otivio AS (FlowOx Home Therapy)

2026 · Ongoing PMCF

Programme Overview

Patient Watch runs the FlowOx programme for Otivio in Denmark (Bandasjist) and Germany (OxyCare). Patients complete the MSIS-29, plus a local symptom scale, in Danish or German. Otivio receives anonymised aggregate exports for post-market surveillance.

•Onboarding covers type of MS, age, time since diagnosis, consent, and a training-video confirmation
•MSIS-29 at baseline, 4 weeks, then every 3 months if use continues
•Denmark uses the Patient-Specific Functional Scale. Germany uses numeric ratings for spasticity, pain, sleep, and fatigue. Both are weekly for the first 4 weeks, then fortnightly
•Reminders and questionnaires are in Danish and German. Otivio receives anonymised aggregate exports

2 MarketsDenmark & Germany dual-language surveillance

Explore post-market surveillance solutions Get a quote

Industry Real-World Evidence Hyaluronic Acid & Viscosupplementation

IBSA

Clinical Setting: IBSA Pharma UK (Sinovial)

Enrolled since February 2026 · follow-up to 6 months

Programme Overview

A live knee audit for IBSA's Sinovial injections. The agreed programme is about 100 patients across participating clinics. Clinic spreadsheets brought into Patient Watch use the Oxford Knee Score, EQ-5D-5L, and a visual analogue scale at baseline, 2 weeks, 12 weeks, and 6 months.

•Oxford Knee Score, EQ-5D-5L, and a visual analogue scale at baseline, 2 weeks, 12 weeks, and 6 months
•Since February 2026: 93.6% of diaries started, 85.5% of entries completed, 59.1% of diaries completed
•Adverse events are part of the platform. IBSA receives aggregate outputs, not patient-level records
•Oxford Knee Score and EQ-5D-5L licence fees are IBSA's responsibility

93.6%diaries started

Read about our real-world evidence programmes Get a quote

Clinical follow-up Sports Medicine & Knee Tendinopathy

Fortius Tendon Clinic

Clinical Setting: Fortius Clinic, London

Agreement February 2026 · 12-month follow-up

Programme Overview

Patient Watch hosts the Elite Tendon pathway for Dr Jonathan Houghton, with Fortius branding. Spreadsheet follow-up is replaced by one cohort: VISA-A or VISA-P, the Patient-Specific Functional Scale, and clinician imaging measures.

•VISA-A or VISA-P, plus the Patient-Specific Functional Scale, at 3, 6, 9, and 12 months, with SMS and email reminders
•Baseline profile: age, elite status, sport, symptom duration, surgical history, and previous treatments such as PRP or shockwave
•Clinician measures include BPI, PTI, CDI, SLFPI, TTTG distance, bone spurs, and tendon dimensions
•Cohort filters and export for the clinic's own audit

VISAA and P at 3, 6, 9 and 12 months

Learn about clinical QIPs and research View our validated questionnaires

Diabetic foot photography Diabetic Foot & Endocrinology

Foot Watch

Clinical Setting: Royal Surrey CEDAR & University of Surrey

12-week pilot

Programme Overview

A 60-patient pilot with CEDAR at Royal Surrey County Hospital and the University of Surrey. After an in-person foot check, patients sent photographs of both feet every two weeks for 12 weeks. Clinicians in orthopaedics, podiatry, and endocrinology scored the photos. Patient Watch Ltd is named on the poster.

•Dorsal and plantar photographs of both feet, every two weeks, compared with the in-person exam
•Photo scores matched or nearly matched the in-person exam in more than 85% of cases. Differences of 2 points or more were under 15%
•Where scores differed systematically, they over-scored rather than under-scored
•System Usability Scale: patients 79.5 ± 15.7 (n=38), clinicians 88.1 ± 8.1 (n=9)

>90%of home photos could be graded

Sources on file

Congress abstract

FootWatch home photography pilot

ATTD (Advanced Technologies and Treatments for Diabetes)

Abstract text is on file. The meeting year and author list are not. Photographs were assessed as suitable for later AI training.

Poster

Remote diabetic foot monitoring

Contact on the poster: Irena Słósarz, CEDAR, Royal Surrey County Hospital

Polish poster. Affiliations: Royal Surrey County Hospital, University of Surrey, Patient Watch Ltd

Same 60-patient pilot. Meeting year is not on file.

View the Foot Watch page See how photo diaries work Explore remote monitoring solutions

Industry Real-World Evidence Orthobiologics & Knee Osteoarthritis

Arthrosamid

Clinical Setting: Contura Orthopaedics & Citius Health

Enrolled since December 2024 · follow-up to 12 months

Programme Overview

Patient Watch collects outcomes for Arthrosamid knee injections with Citius Health, including the Retired Athletes programme. On the live engagement dashboard, 89.1% of diaries were started, 67.2% of entries were completed, and 61.2% were on time.

•Waiting-room QR onboarding and digital consent, as described on the programme page
•WOMAC, Oxford Knee Score, EQ-5D, and a visual analogue scale, with follow-ups at 3, 6, 9, and 12 months
•More than 100 knee injection patients enrolled since December 2024
•67.2% of diary entries completed, 61.2% on time

89.1%diaries started

View the Arthrosamid programme page Explore real-world evidence solutions

NHS clinical pathway Spinal Surgery & Nerve Root Pain

Sheffield Spine nerve root diary

Clinical Setting: Sheffield Teaching Hospitals NHS Foundation Trust

2025 · 6-week pathway

NHS Sheffield Spine Service

Programme Overview

A Patient Watch pain diary for lumbar nerve root injections at Sheffield. Patients score back pain and leg pain separately. The care team reviews the diary 4 to 6 weeks after the injection.

•Reminders on injection day (before and shortly after), at 6 hours, on days 1 and 2, and then weekly
•Back pain and leg pain are each scored from 0 to 10
•The patient guide links to nerve root injection information and a physiotherapy page

73%engagement

View the Sheffield Spine patient guide Nerve root pain information for patients

Published research Foot and ankle orthopaedics

Royal Surrey injection follow-up

Clinical Setting: Royal Surrey NHS Foundation Trust

EFORT 2022 · journal paper 2025

Programme Overview

Published Royal Surrey research, collected on paper before Patient Watch ran the diaries. Fan and colleagues followed 104 foot and ankle injection patients with visual analogue scale diaries. About 9% needed a review inside the usual 6-8 week window. The estimated saving from those avoided early appointments was £9,500 - £19,000 per 100 patients.

•Paper visual analogue scale diaries, completed by patients and held by the Royal Surrey team
•Median time to a requested follow-up was 117 days
•43% of patients never requested a follow-up
•Authors: Ka Siu Fan, Iqraa Haq, Ali Taha, Andrew Carne, Chintu Gademsetty, and Matthew Solan

91%did not need a routine 6-8 week review

Sources on file

Peer-reviewed paper2025

Efficient patient-initiated follow-up after orthopaedic injections

Fan, Haq, Taha, Carne, Gademsetty, and Solan

European Journal of Orthopaedic Surgery & Traumatology (35, 77)

DOI: 10.1007/s00590-025-04193-9

Congress abstractMay 2022

Efficient Follow-Up After Orthopaedic Injections

Royal Surrey

EFORT

104 patients. Pain diary results compared with appointments over 3 years. About 9% benefitted from routine follow-up.

Read our full Royal Surrey PIFU analysis Explore the pain injections setup

Run a study or QIP with Patient Watch

NHS follow-up and industry outcome programmes are scoped to the questionnaires and the schedule you actually need.

Get a quote Browse outcome measures